Bristol-Myers Squibb Company (BMY) Financials

BMY Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 95.2 billion 65.7 billion
2023-09-30 91.3 billion 62.2 billion
2023-06-30 93.5 billion 61.5 billion
2023-03-31 94.3 billion 62.4 billion

BMY Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 3.9 billion 127.0 million
2023-09-30 4.4 billion 132.0 million
2023-06-30 1.6 billion 137.0 million
2023-03-31 2.7 billion 122.0 million

BMY Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-12-31 1.8 billion
2023-09-30 1.9 billion
2023-06-30 2.1 billion
2023-03-31 2.3 billion

BMY Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 12.3 billion - 1.7 billion
2023-09-30 7.7 billion 32.1 billion 1.7 billion
2023-06-30 8.4 billion 34.7 billion 1.5 billion
2023-03-31 9.0 billion 35.1 billion 1.5 billion

BMY Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 2.0 billion
2023-09-30 2.1 billion
2023-06-30 2.1 billion
2023-03-31 2.1 billion

BMY Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 330.0 million 2.5 billion 2.1 billion -
2023-09-30 342.0 million 2.2 billion 1.9 billion 2.0 billion
2023-06-30 259.0 million 2.3 billion 1.9 billion -
2023-03-31 278.0 million 2.3 billion 1.8 billion 1.8 billion

BMY Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 11.5 billion 2.7 billion
2023-09-30 11.0 billion 2.5 billion
2023-06-30 11.2 billion 2.9 billion
2023-03-31 11.3 billion 2.6 billion

BMY

List: Contenders

Price: $48.93

52 week price:
47.58
70.94

Dividend Yield: 0.04%

5-year range yield:
0.04%
4.76%

Forward Dividend Yield: 4.90%

Payout Ratio: 62.18%

Payout Ratio Range:
-9751.24%
202.32%

Dividend Per Share: 2.40 USD

Earnings Per Share: 3.80 USD

P/E Ratio: 12.90

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - General

Volume: 10.2 million

Ebitda: 946.0 million

Market Capitalization: 104.2 billion

Average Dividend Frequency: 4

Years Paying Dividends: 53

DGR3: 8.88%

DGR5: 7.07%

DGR10: 4.91%

DGR20: 3.52%

Links: